CrossrefInfokarte
Refining High-Risk EGFR-Mutant Lung Cancer Patients: The Role of Adjusted Variant Allele Frequency in First-Line Osimertinib Therapy
Clinical Lung Cancer · 2026-03 · 27 (2) · 146-150.e2
DOI: 10.1016/j.cllc.2025.08.014 ↗Abstract
Kein Abstract verfügbar.
EUVIMED